TransDigm (TDG) director granted 518 options at $1,291.97
TransDigm Group (TDG) reported a Form 4 for a director, reflecting a grant of stock options for 518 shares on November 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
Rhea-AI Filing Summary
TransDigm Group (TDG) reported a Form 4 for a director, reflecting a grant of stock options for 518 shares on November 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
The options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets. Following the grant, the reporting person held 518 derivative securities directly. The derivative security is a stock option on TransDigm common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options are exercisable at 20% per year over five years beginning September 30, 2026 subject to the achievement of annual operating performance targets in each year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TransDigm (TDG) disclose in this Form 4?
What is the vesting schedule for the TDG options?
When do these TDG options expire?
What is the ownership form after the transaction?
What transaction code was used?
AI-generated analysis. How Rhea-AI works. Not financial advice.